Clinical and prognostic implications of low or high level of von Willebrand factor in patients with Waldenstrom macroglobulinemia

Shear stress-induced unfolding of VWF accelerates oxidation of key methionine residues in the A1A2A3 region

(2011) X. Fu et al.   BLOOD

How I treat the acquired von Willebrand syndrome

(2011) A. Tiede et al.   BLOOD

Evidence-based focused review of management of hyperviscosity syndrome

(2011) M. J. Stone et al.   BLOOD

Comprehensive analysis of tumor microenvironment cytokines in Waldenstrom macroglobulinemia identifies CCL5 as a novel modulator of IL-6 activity

(2011) S. F. Elsawa et al.   BLOOD

Endothelial von Willebrand factor regulates angiogenesis

(2010) R. D. Starke et al.   BLOOD

International prognostic scoring system for Waldenstrom macroglobulinemia

(2009) P. Morel et al.   BLOOD

Mechanisms underlying acquired von Willebrand syndrome associated with an IgM paraprotein

(2009) M. Mayerhofer et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

CD27-CD70 interactions in the pathogenesis of Waldenstrom macroglobulinemia

(2008) A. W. Ho et al.   BLOOD

Mast cells and mastocytosis

(2008) D. D. Metcalfe   BLOOD

Thrombospondin-1 in Von Willebrand Factor Function

(2008) Arnaud Bonnefoy et al.   CURRENT DRUG TARGETS

Update on Treatment Recommendations From the Fourth International Workshop on Waldenström's Macroglobulinemia

(2008) Meletios Athanasios Dimopoulos et al.   JOURNAL OF CLINICAL ONCOLOGY

Protein kinase C-δ mediates von Willebrand factor secretion from endothelial cells in response to vascular endothelial growth factor (VEGF) but not histamine

(2008) O. LORENZI et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

(2007) E. Hoster et al.   BLOOD